FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Medreleaf

  • Home
  •  | 
  • Tag Archives: "Medreleaf"

Aurora Cannabis Receives Production License for Aurora Eau Facility and Oils Production License for MedReleaf’s Bradford Facility

Aurora Cannabis Receives Production License for Aurora Eau Facility and Oils Production License for MedReleaf’s Bradford Facility
Sept. 7, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that the Company has received a Health Canada production license for its Aurora Eau facility in Lachute, Quebec. The Company now has seven facilities licensed for production, with a combined production capacity in excess of 160,000 kg per annum. Aurora has additional facilities under development, bringing the total funded capacity to more than 500,000 kg per annum.
Read more

ONTARIO CANNABIS STORE SECURES SUPPLY AGREEMENTS WITH LICENSED PRODUCERS TO ENSURE READINESS FOR LEGALIZATION

ONTARIO CANNABIS STORE SECURES SUPPLY AGREEMENTS WITH LICENSED PRODUCERS TO ENSURE READINESS FOR LEGALIZATION
Supply agreements with authorized Health Canada producers were achieved through a competitive process, resulting in a range of cannabis products and size formats among the categories of dried flower, cannabis oil and cannabis seeds. In the coming months, the OCS will continue to hold competitive product calls to expand its selection of available cannabis products and to be responsive to the preferences of Ontario customers. The OCS is also working to finalize supply agreements with cannabis accessory suppliers to ensure a diverse selection of accessories is also available for customers.
Read more

Aurora Cannabis and MedReleaf Close the World’s Largest Cannabis Industry Transaction

Aurora Cannabis and MedReleaf Close the World’s Largest Cannabis Industry Transaction
Aurora Cannabis Inc. ("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and MedReleaf Corp. ("MedReleaf") (TSX: LEAF) today announced the closing of the previously announced arrangement agreement (the "Arrangement Agreement"). Under the terms of the Arrangement Agreement, holders of MedReleaf common shares received 3.575 common shares of Aurora for each MedReleaf common share held (the "Exchange Ratio").
Read more

MEDRELEAF ACQUIRES MED COLOMBIA

MEDRELEAF ACQUIRES MED COLOMBIA
Medreleaf Corp. has acquired MED Colombia SAS, a company with licences in Colombia to cultivate cannabis and produce cannabis oil extracts (along with a library of cannabis genetics), for a total consideration of 2.75 million euros in cash. This acquisition provides Medreleaf with the ability to produce low-cost, high-quality raw materials to serve its global supply chain, as well as the domestic Colombian medical cannabis market.
Read more